Eyes with end-stage neovascular glaucoma. Natural history following successful modified filtering operation

Richard K Parrish, J. Herschler

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

A modified filtering operation for neovascular glaucoma provided control of intraocular pressure 12 to 23 months in ten of 13 eyes. After long-term follow-up, 23 to 54 months, seven of ten eyes still had controlled IOP. Two eyes were receiving no medication, two required miotics, and three required maximal medical therapy, including carbonic anhydrase inhibitors. One eye had undergone cyclocryotherapy four years after trabeculectomy. Four of seven eyes with diabetic neovascular glaucoma retained ambulatory vision. The eye with neovascular glaucoma from central retinal vein occlusion lost useful vision. The underlying disease process is an important determinant of surviving visual function.

Original languageEnglish
Pages (from-to)745-746
Number of pages2
JournalArchives of Ophthalmology
Volume101
Issue number5
StatePublished - Jan 1 1983

Fingerprint

Neovascular Glaucoma
Natural History
Miotics
Carbonic Anhydrase Inhibitors
Retinal Vein
Retinal Vein Occlusion
Trabeculectomy
Intraocular Pressure

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Eyes with end-stage neovascular glaucoma. Natural history following successful modified filtering operation. / Parrish, Richard K; Herschler, J.

In: Archives of Ophthalmology, Vol. 101, No. 5, 01.01.1983, p. 745-746.

Research output: Contribution to journalArticle

@article{ed1080dd12854b61b45284905e40d402,
title = "Eyes with end-stage neovascular glaucoma. Natural history following successful modified filtering operation",
abstract = "A modified filtering operation for neovascular glaucoma provided control of intraocular pressure 12 to 23 months in ten of 13 eyes. After long-term follow-up, 23 to 54 months, seven of ten eyes still had controlled IOP. Two eyes were receiving no medication, two required miotics, and three required maximal medical therapy, including carbonic anhydrase inhibitors. One eye had undergone cyclocryotherapy four years after trabeculectomy. Four of seven eyes with diabetic neovascular glaucoma retained ambulatory vision. The eye with neovascular glaucoma from central retinal vein occlusion lost useful vision. The underlying disease process is an important determinant of surviving visual function.",
author = "Parrish, {Richard K} and J. Herschler",
year = "1983",
month = "1",
day = "1",
language = "English",
volume = "101",
pages = "745--746",
journal = "JAMA Ophthalmology",
issn = "2168-6165",
publisher = "American Medical Association",
number = "5",

}

TY - JOUR

T1 - Eyes with end-stage neovascular glaucoma. Natural history following successful modified filtering operation

AU - Parrish, Richard K

AU - Herschler, J.

PY - 1983/1/1

Y1 - 1983/1/1

N2 - A modified filtering operation for neovascular glaucoma provided control of intraocular pressure 12 to 23 months in ten of 13 eyes. After long-term follow-up, 23 to 54 months, seven of ten eyes still had controlled IOP. Two eyes were receiving no medication, two required miotics, and three required maximal medical therapy, including carbonic anhydrase inhibitors. One eye had undergone cyclocryotherapy four years after trabeculectomy. Four of seven eyes with diabetic neovascular glaucoma retained ambulatory vision. The eye with neovascular glaucoma from central retinal vein occlusion lost useful vision. The underlying disease process is an important determinant of surviving visual function.

AB - A modified filtering operation for neovascular glaucoma provided control of intraocular pressure 12 to 23 months in ten of 13 eyes. After long-term follow-up, 23 to 54 months, seven of ten eyes still had controlled IOP. Two eyes were receiving no medication, two required miotics, and three required maximal medical therapy, including carbonic anhydrase inhibitors. One eye had undergone cyclocryotherapy four years after trabeculectomy. Four of seven eyes with diabetic neovascular glaucoma retained ambulatory vision. The eye with neovascular glaucoma from central retinal vein occlusion lost useful vision. The underlying disease process is an important determinant of surviving visual function.

UR - http://www.scopus.com/inward/record.url?scp=0020537120&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020537120&partnerID=8YFLogxK

M3 - Article

C2 - 6189472

AN - SCOPUS:0020537120

VL - 101

SP - 745

EP - 746

JO - JAMA Ophthalmology

JF - JAMA Ophthalmology

SN - 2168-6165

IS - 5

ER -